Dosimetry during adjuvant (131)I therapy in patients with differentiated thyroid cancer-clinical implications

The activity of radioiodine ((131)I) used in adjuvant therapy for thyroid cancer ranges between 30 mCi (1.1 GBq) and 150 mCi (5.5 GBq). Dosimetry based on Marinelli's formula, taking into consideration the absorbed dose in the postoperative tumour bed (D) should systematise the determination of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Szumowski, Piotr, Abdelrazek, Saeid, Iwanicka, Dorota, Mojsak, Małgorzata, Sykała, Monika, Żukowski, Łukasz, Siewko, Katarzyna, Adamska, Agnieszka, Maliszewska, Katarzyna, Popławska-Kita, Anna, Szelachowska, Małgorzata, Krętowski, Adam, Myśliwiec, Janusz
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260769/
https://ncbi.nlm.nih.gov/pubmed/34230618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93431-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados